Page last updated: 2024-11-08

3-n-butyl-4,5-dihydrophthalide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-N-butyl-4,5-dihydrophthalide: from seeds of Apium graveolens Linn.; RN given refers to (-)-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
ApiumgenusA genus comprising several species of flowering plants with global distribution in the family APIACEAE.[MeSH]ApiaceaeA large plant family in the order Apiales, also known as Umbelliferae. Most are aromatic herbs with alternate, feather-divided leaves that are sheathed at the base. The flowers often form a conspicuous flat-topped umbel. Each small individual flower is usually bisexual, with five sepals, five petals, and an enlarged disk at the base of the style. The fruits are ridged and are composed of two parts that split open at maturity.[MeSH]
Apium graveolensspeciesA plant species of the family APIACEAE. The stalks are a food source.[MeSH]ApiaceaeA large plant family in the order Apiales, also known as Umbelliferae. Most are aromatic herbs with alternate, feather-divided leaves that are sheathed at the base. The flowers often form a conspicuous flat-topped umbel. Each small individual flower is usually bisexual, with five sepals, five petals, and an enlarged disk at the base of the style. The fruits are ridged and are composed of two parts that split open at maturity.[MeSH]

Cross-References

ID SourceID
PubMed CID173843
CHEMBL ID2288883
SCHEMBL ID4086957
MeSH IDM0133135

Synonyms (15)

Synonym
3-butyl-4,5-dihydro-3h-2-benzofuran-1-one
62006-39-7
3-n-butyl-4,5-dihydrophthalide
166733-97-7
FT-0688347
CHEMBL2288883
SCHEMBL4086957
ZPIKVDODKLJKIN-UHFFFAOYSA-N
3-butyl-4,5-dihydrophthalid
3-butyl-4,5-dihydro-2-benzofuran-1(3h)-one
DTXSID40977545
3-butyl-4,5-dihydroisobenzofuran-1(3h)-one
AKOS037515468
B2703-407024
FS-10382

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" For metabolite profiling and identification, senkyunolide A (10 μM) was incubated with hepatocytes and the incubation samples were analyzed by ultra-high-performance liquid chromatography combined with diode-array detector and high-resolution mass spectrometry (UHPLC/DAD-HRMS)."( Metabolic profiling of senkyunolide A and identification of its metabolites in hepatocytes by ultra-high-performance liquid chromatography combined with diode-array detector and high-resolution mass spectrometry.
Liu, C; Sui, Y; Wang, M; Zhang, H, 2020
)
0.56

Bioavailability

ExcerptReferenceRelevance
"01 hours), and the bioavailability was 75%."( Low oral bioavailability and pharmacokinetics of senkyunolide a, a major bioactive component in Rhizoma Chuanxiong, in the rat.
Ko, NL; Lin, G; Tam, YK; Yan, R, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1110758Nematocidal activity against Panagrellus redivivus assessed as mortality at 12.5 ug/ml2002Annual review of phytopathology, , Volume: 40Phytochemical based strategies for nematode control.
AID1110757Nematocidal activity against Caenorhabditis elegans assessed as mortality at 50 ug/ml2002Annual review of phytopathology, , Volume: 40Phytochemical based strategies for nematode control.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (42)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (4.76)18.7374
1990's3 (7.14)18.2507
2000's12 (28.57)29.6817
2010's21 (50.00)24.3611
2020's4 (9.52)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.30 (24.57)
Research Supply Index3.83 (2.92)
Research Growth Index5.13 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.22%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other44 (97.78%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]